Cynthia Accuosti Jones is Vice President, Commercial Autoantibody and Maternal Fetal Disease Area Leader at Janssen Global Services. In this role, she is responsible for developing and executing the global commercial strategy to support the discovery, development, and launch of new therapies to address auto and alloantibody-driven diseases, with a focus on maximizing the value and patient impact of therapeutic assets across indications spanning from maternal fetal, rare autoantibody, and prevalent rheumatology.
Prior to her current role, Cynthia served as the Director of Marketing for the Prostate Portfolio within Janssen Oncology, responsible for ERLEADA® (apalutamide) and the launch readiness planning for the niraparib/abiraterone dual-action tablet. Prior to this role, she held multiple positions within the Janssen Oncology marketing team, and since joining Janssen in 2004, has demonstrated a track record of success across Marketing, Account Management, Pricing Strategy, and Finance.
Cynthia holds a B.S. dual degree in Finance & International Business from Georgetown University, and a master’s certificate in Health Policy from Thomas Jefferson University. She is also a Tribute to Women and Industry (TWIN) recipient, and was named a Healthcare Women’s Business Association Rising Star in 2015.
Follow Cynthia on LinkedIn here